| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 7e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 6e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |